NCBI Summary
The ficolin family of proteins are characterized by the presence of a leader peptide, a short N-terminal segment, followed by a collagen-like region, and a C-terminal fibrinogen-like domain. The collagen-like and the fibrinogen-like domains are also found separately in other proteins such as complement protein C1q, C-type lectins known as collectins, and tenascins. However, all these proteins recognize different targets, and are functionally distinct. Ficolin 1 encoded by FCN1 is predominantly expressed in the peripheral blood leukocytes, and has been postulated to function as a plasma protein with elastin-binding activity. [provided by RefSeq, Jul 2008].
Protein
Protein (NP_001994)
M-ficolin
Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin)
FCN1
ficolin 1
Undefined
Curated
Ficolin-like
Ficolins
a/b mixed with b-sheet / Fibrinogen C-ter like
0.819
Protein sequence and protein families (fasta) (326 amino acids) Download
MELSGATMARGLAVLLVLFLHIKNLPAQAADTCPEVKVVGLEGSDKLTILRGCPGLPGAPGPKGEAGVIGERGERGLPGAPGKAGPVGPKGDRGEKGMRGEKGDAGQSQSCATGPRNCKDLLDRGYFLSGWHTIYLPDCRPLTVLCDMDTDGGGWTVFQRRMDGSVDFYRDWAAYKQGFGSQLGEFWLGNDNIHALTAQGSSELRVDLVDFEGNHQFAKYKSFKVADEAEKYKLVLGAFVGGSAGNSLTGHNNNFFSTKDQDNDVSSSNCAEKFQGAWWYADCHASNLNGLYLMGPHESYANGINWSAAKGYKYSYKVSEMKVRPA
Mol* PDB structure viewerUniLectin3D
Structural models
Model Confidence:
  •    Very high (pLDDT > 90)
  •    Confident (90 > pLDDT > 70)
  •    Low (70 > pLDDT > 50)
  •    Very low (pLDDT < 50)

  AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Some regions with low pLDDT may be unstructured in isolation.


Ligand
Glycan ligands from structural data
GlcNAc
GlcNAc
GalNAc
GalNAc
NeuAc
NeuAc
References
NCBI References (10 PubMed Identifiers)
  • Association of ficolin-1 and ficolin-3 gene variation and pulmonary tuberculosis susceptibility in a Chinese population. [33591573]
  • Association between serum ficolin-1 level and disease progression in primary biliary cholangitis. [32915797]
  • Associations of ficolins and mannose-binding lectin with acute myeloid leukaemia in adults. [32601370]
  • Ficolin-1 gene (FCN1) -144 C/A polymorphism is associated with adverse outcome of severe pneumonia in the under-five Egyptian children: A multicenter study. [32142211]
  • Sickening or Healing the Heart? The Association of Ficolin-1 and Rheumatic Fever. [30619357]
  • Characterization of ficolins as novel elastin-binding proteins and molecular cloning of human ficolin-1. [8947836]
  • Cloning and characterization of the human lectin P35 gene and its related gene. [8884275]
  • A novel human serum lectin with collagen- and fibrinogen-like domains that functions as an opsonin. [8576206]
  • Human ficolin: cDNA cloning, demonstration of peripheral blood leucocytes as the major site of synthesis and assignment of the gene to chromosome 9. [8573080]
  • Molecular cloning and characterization of ficolin, a multimeric protein with fibrinogen- and collagen-like domains. [7686157]
UniProt Main References (10 PubMed Identifiers)
  • Complete sequencing and characterization of 21,243 full-length human cDNAs. [14702039]
  • DNA sequence and analysis of human chromosome 9. [15164053]
  • The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). [15489334]
  • Signal peptide prediction based on analysis of experimentally verified cleavage sites. [15340161]
  • Secreted M-ficolin anchors onto monocyte transmembrane G protein-coupled receptor 43 and cross talks with plasma C-reactive protein to mediate immune signaling and regulate host defense. [21037097]
  • Tethering of Ficolin-1 to cell surfaces through recognition of sialic acid by the fibrinogen-like domain. [20400674]
  • Trivalent recognition unit of innate immunity system: crystal structure of trimeric human M-ficolin fibrinogen-like domain. [17148457]
  • Structural basis for innate immune sensing by M-ficolin and its control by a pH-dependent conformational switch. [17897951]
  • Carbohydrate recognition properties of human ficolins: glycan array screening reveals the sialic acid binding specificity of M-ficolin. [20032467]
  • The consensus coding sequences of human breast and colorectal cancers. [16959974]
RNA
RNA (Transcript ID: NM_002003.5)
ficolin 1
m7G-5')ppp(5'-GUUAGAGCUGGGGGACUCUUCAGAGUCAAAGGCCAGAGAGCAUGGAGCUGAGUGGAGCCACCAUGGCCCGGGGGCUCGCUGUCCUGCUAGUCUUGUUCCUGCAUAUCAAGAACCUGCCUGCCCAGGCUGCGGACACAUGUCCAGAGGUGAAGGUGGUGGGCCUGGAGGGCUCUGACAAGCUCACCAUUCUCCGAGGCUGCCCGGGGCUGCCCGGGGCCCCAGGGCCAAAGGGAGAGGCAGGUGUCAUUGGAGAGAGAGGAGAACGCGGUCUCCCUGGAGCCCCUGGAAAGGCAGGACCAGUGGGGCCCAAAGGAGACCGAGGAGAGAAGGGGAUGCGUGGAGAGAAAGGAGACGCUGGGCAGUCUCAGUCGUGUGCGACAGGCCCACGCAACUGCAAGGACCUGCUAGACCGGGGGUAUUUCCUGAGCGGCUGGCACACCAUCUACCUGCCCGACUGCCGGCCCCUGACUGUGCUCUGUGACAUGGACACGGACGGAGGGGGCUGGACCGUUUUCCAGCGGAGGAUGGAUGGCUCUGUGGACUUCUAUCGGGACUGGGCCGCAUACAAGCAGGGCUUCGGCAGUCAGCUGGGGGAGUUCUGGCUGGGGAAUGACAACAUCCACGCCCUGACUGCCCAGGGAAGCAGCGAGCUCCGUGUAGACCUGGUGGACUUUGAGGGCAACCACCAGUUUGCUAAGUACAAAUCAUUCAAGGUGGCUGACGAGGCAGAGAAGUACAAGCUGGUACUGGGAGCCUUUGUCGGGGGCAGUGCGGGUAAUUCUCUAACGGGCCACAACAACAACUUCUUCUCCACCAAAGACCAAGACAAUGAUGUGAGUUCUUCGAAUUGUGCUGAGAAGUUCCAAGGAGCCUGGUGGUACGCCGACUGUCAUGCUUCAAACCUCAAUGGUCUCUACCUCAUGGGACCCCAUGAGAGCUAUGCCAAUGGUAUCAACUGGAGUGCGGCGAAGGGGUACAAAUAUAGCUACAAGGUGUCAGAGAUGAAGGUGCGGCCCGCCUAGACGGGCCAGGACCCCUCCACAUGCACCUGCUAGUGGGGAGGCCACACCCACAAGCGCUGCGUCGUGGAAGUCACCCCAUUUCCCCAGCCAGACACACUCCCAUGACGCCCACAGCUGCCCCUUUGCCCCCAGCUCAGUCAAGCCGCCACAUGCCCACAACCUCACCAGAGGGAGAAUUAUGUUUCUAAAUAUGUUUACUUUGGGACAGAAAAGUUUUACCAGUUUCAAUGUGUGUUUCUUGAACACCAGUGGUUUUGAUCACUUUCCUGUGUCUGUUGCACGGCAGGUCUUUCCCUGGAAUUUGGUAAGUCGGGAAGAGUCAGGACCCUUAUUUAGCAGAUGGCACUACCGAUGUUCAGGGAGGUUGAGUGACUUUUGCGAGGAUUUUCCACCUCCAGUAAUUGACACAGGGCGAUCCUCACCUCCACCCCCAAGCCUCCCCCAUCCCCCCAUGCCUCACUCACAACACUUCACACUUCUUGAAAAAGGUCACUUUGGGGUCCAGAAAACACUUACUAAAAAGGGGGAAAGUUUAGUAGGAACUUUUCUGCUUCCCACCACGGCAGAGUUCAUGCUUUGGGCUGGCUGGCUGCUGGGAAGAGAUAAACACUUAGCACUCACUAAGUGAGCGCCUGGUCAGCCACCUGCACAGAGAAGAUUCCGAAGAGGCCUUCCUCCCACACACAGACCUCAGCUAGAGGGGACCGCGGACCUCAGUGGGAAAAGCUGCACAAGGCUUCUAGGAGAUGAUGGAGAAGGGGCUUCUCCAGCUCCCAGGCCAGGGGAGAUUUCUCAACCACGACCUAAGAAGCAUCAAAGGGAAUGUGGCAAGUGUGACUCCAUUCAAAUCAAGAGCUCCCACUUACCGAAGGACACUAAGGGAACCAAAGGAAGGCCAGAGGGGCAGAAUCAACGUGCGGCACACAAAUCUUUAGUUUUCUACUAUUGCCGCAACCAGUCACCACAAAUGGAGUGGCUUGAAACAACAAGAACUCGCCACCUCCUGGCUCAGUAGAUCUGGAGUCCCUGGGCCUUACUGGGCCAGCAGGCAGGACUCAGCAGUGGUGGCUCCUUCCAGGGUUCUAGGGGAGAACCUGCUUCCUUGCCUUUUCCAGCCCCAGGGGUCACUGGCAUUCAUUGGCCCGGACUCCUUCCCCCAACCCCAAAGCCAGCAGCACCACAUCUCUCUGACCCUUCAUCCGUUGUCCCCUCUCCCCCCAAGCCCCAUGGGACAGGGUCUCCACUCCUGAGACUCAUGGGAUUAGACUAGGCCUACCUGGAUGAUCUGGGAUCCUCUCCCAUGUCCAGGUCUCUAUCCCUAACCACAUCAGCAAAGUCUCUUUUGCCAUGGAAGGUAUUUGCAGGCUCUGACUUUGUGUGUAUUAGGGCAGGACAUUUUUGGCGGGGCAGUGGUGGGGGCAGGGAAUUAUUCUGCCUACCAUGCCUUAUACAAAAAUAAAUAAAUCACAGGCUUAUACCUGAAAGAAUUCCUGCAAAUAAUAAAAGAAUUAGAGCAGCUCAGUUAAAUAAAAAAAGGUAUGAGAUGUGAACAGACACUUCACAGAAGAUGACAUGCAGGGGAGCAAGGUAUUUAUCAAAAAGUGCUCCACUUUUCACUUACCAGAGAAAUGCAAAUCAGCACCCAAAGGAGUCACUGCGGCACCCUCAUCUGAGCCUCAGAAGUUAGAAAGAUGGAUAGCACCAGUGUCAAAGGUGACUGUGGGAGGGAGAUUUGCAUACACUGCUAGUAACAAUGCGAAUUGAUGGAACCAACCUGGAAAAUGGCUUGGCAUCAACUGUUGGAGAAGAAGACACACAGUCCUCUAACCUGCCAGUCCCACAUCAGGGCCUGGAUAUGGCCGUCAUGUGUACCAGGGAGCAUGGCCAGGAAUCUUUACAGCCAAAUACUCACCAUAGCACCAAACUGGAAUCAGCCGACAUACCCAUCAGGAAGAGAAUGGAUGUUAAAAAAUGCAAGGAUAGCCAUUGGGUAGAACGCCAUACAGCCAUGACAAUUACACAGUGACACCUACACACAAGGAGCAUGAGUCUCACAAACAUGGCAGCAAAAGGAGCCUGUUCAAGAGGGUAUGUGCUAUGGAUUCCAUUGUAGAUAAAGUUUUUCAAAAGCAAAAGUAGCCAAUGGUAUUUUGGAUGCAUAUUUAGGUGGUAAAUGUAUACAGGAAAAAUAAGAAAGUGAUUGUAUUUGAGGGUGGGACCACAUGGUGACUGGGAAGGGACAGGGACAAGCCUCUGGGGUUCUGGCAAUGCUCUGUUUCUUGACCCAGGUGGUGAUUGUAAGGAUGUUUGUUAACUAGUGAUGAAAAUAAUUAAGCUGUACUUUUGCUUUAUACACUUUUGAGUACAUGUUAUGUUCCACAAUUUAAAAACUACUUAUAAAGAAACUGCACAUGCUUGGAUCCAGGAACAUGAGCUACAGGCACAUCCUCCACUGAUGCCCAGUGUUCUUGACUCAAUACCUGUAAGGAGAGGUCCUUGUAGCCCAUUGGGGGCUGACCAGACCCUACUACGCCCCUGCCACAAUCUCUAGUCCAUCACAAAAUCCACUAUUGGGAUAGUACUUUCGUCCCUCAGUAGGUAAGCAUUUUUACAACCUAGGAAGACUUAGCUUUAAGUCUAGAAAUGAUUAGUAUAAAUAUAAAAUAUAAAUAUGAUUAAUAUAAAUAUAAAAUAGCCAUAGAAAUAUGCCUUUUAGUUUGUUUUUUGAGACAGAGUUUUACUCUGCCACCCAGGCUGGAGUGCAGUGGCGUGAUCUCAGCUCACUGCAAUCUCCACCUCCCAGGUUCAAGAGAUUCUCAUGCUUCAGCCUCCCAAGUAGCUGGGAUCACAGGCACACACAACCAUGCCCAGCAAUUUUUUUGUAUUUUUAGUAGAGAUGGGGUUUCGCCGUGUUGGCCAGGCUGGUCUUGAACUCCCGACCUCAAGUGAUCCACCCGCCUCUGCCUCCCAAAUUGCUGAGAUUACAGGCGUGAGACACUGUGCCUGGCCAAAAUAUGCCUUUUGUAUUAAGGAAUCUGGACAGGUUUGAUUUUUCACAGUCUUGUAAUGUUUAAAUAAUUUGGCCUAUUAUGAAGAAUCUCACAAAUCCAAUAUAAAAUGUGGAACUAACUAAUCAAAAUCAUCUUGUAAUAUUACAUGGAAAUCUUAGUGCGUUUAUACACGGUAUUGGCAUAUUUAAGAGACUUUGAGCUCAUUGCAUUUCUAAGUUAAAUUAUUAGAUUUCUUAAGAUUUAAGUUAAAUUAUUAGAUUUUUAAAGAUUAAUUAGUGCUAAGGAGGGUUUUCUCAUUAGACAGCUGAAAUGCCGCAGGAGAAAUUUGAGUGUAUUCCACUUCUUAUUGCAAUUUUAAAUGUUUGAAGUUAUUUAAAGAACUAAAUUUAUGGUAUCCAAAAGCUCUAAAAAGGUGACUCUUAAGAUUUGCAGGUCUUAUAAAUAGAAAAACAAGAACUGUAAGCCAAACUUAAAAUAUUCAGGAUGAAUUGAGUUUUUGAAUUUGUAGCUUUCAGAAACUGAACAUUAAUUUUAAGAAGCAAAGCAGGCUGGGCACAGUGGCUCACGCCUGUAAUCCUAGCACUUUAGGAGGCUGAAGUGGGUGGAUCACUUGAGAUCAGGAGUUCAAGACCAGCCUGGCCAACAUGAUGAAACCUCCUCUCUACUAAAAAUACAAAACUCCGCCAGAAAUCGCUUGAUCCCGGGAGGUGGAGGUUGCAGUGAGCUGAGAUCGUGCCACUGCACUCCAGCCUGGGGAACAGAGCGAGAUUCCGCCUCAAAAAAAAAAUAAAAAUAAAAAGAAGAAGAAGAAGAAGGAGAAAGAGGGAGAGGGAGAGGGAGAGGGAGAGGGAGAGGGAGAGGGAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAAGAGGAAGAGGAAGAGGAAGAGGAAGAGGAAGAGGAAGAGGAAGAAGAAGAAGAAGAGGAAGAAGAAGAAGAAGCAGCAGCAGCGGCCAGGCGCGGUGGCUCACGCUUGUAAUCCCAGCACUUUGGGAGGCCGAGGCGGGCGGAUCACAAGGUCAGGAGAUCAAGACCAUCCUGGCUAACAUGAUGAAACCCCGUCUCUACUAAAAAUACAAAAAAAUUAGCCGUUCAUGGUGGGGGAUGCCUAUCGUCCCAGCUACUCGAGAAGCUGAGGCAGGAGAAUGGCGUGAACCCAGGAGGCAGAGGUUGAAGUGAGCCGAGAUCGCACCACUGCACUCCAGCCUGGGCGACAGAGCGAGACUCUGUCUCAAAAUAAAAGAAGCAAAGCAAGCUUAUGAAGAGAUGAAGAGUCUUUUCCCAUCACCAAUUCCUCCCCAACUCACAUCAGCAGAACUGAGAGAGCUUUUGUGAUUUGAGGGAUAAAGCUGAAUGGGUGAAAAGAAAUCAAGCCCUCCUCCUCUUGGGCCAGUGCUCUUCUUCCUGGCCAUGGGACCUCUCAAGUAGGAGUGUAGGCGUGGGCCCAUCCAGCAACAUUUGGGCAUUCGUGGACAUCCACAUAGUGUUGUUUCUGUUCUUUUCCUCUCCUUCCUCAUCUUCUCUCGUCUUUGUUGAAUAUUUUUAUUAUCCCGUCACCUCCUCUAUCAGCUUAUAACUUGUUCAUUCUUUUCCUAUCUUUUGGUGUUUAUGCUUGCGAUUGCAAUAUAUAGCCUUGAUUUUUUACGGUAUACUAUAAAUUAUUCCUUCUACCACUUUACCAAUGAAGACUUUGAAACACCUCUAACUACAUUCACUCCCUUCUGCUUUUUAUGCCAUUCUUGCCGCCAUGCUAUGAUACAUUUAUUUAAAGUCCUGCAAGAAAUGGCUAUUAGUAUUGUUUUGUGCAGUCCGUAUUCAUUUUUACCACAUUUUUACACUUUAUGUUGCCCUUUAUUCCUUCUUCUAUUUUAUUAUUAUUAUUAUUUUUGGUGUGAGAUCAUCUUCUUGCUGCCUGACAAACUCCCUUUCAUAUAUAUUUUUUAUUUUUAUUUUUUGAAACAGGGUCUCACUCUGUCCCCCAGGCUGGAGUGCAGCGGUAUGACCUUAGCUCACUGCAACCUCCACCUCCUGGGCUCAAACAAUUCUCCUGCCUCAGCUUCCCGUGUAGCUGGGACUACAGGUGUGCACCACUACGCUGGGCUAAUUUUUGUAUUUUUUGGUAGAGAUGGGGUUUCGCCAUGUUAGCCAGGCUGCUCUUGAACUCCUGACCUCAAGUGAUCCACCCGCCUCAGCCUCCCAAAGUGCUAGGAUUACAGAUGUGAGACACCGUGCCCAGCCUCAUAUAUUUUUUGAUGAAAGUCUGCUGAGGAUGAAUUCUGUCCACUUUUAUUAUCUGAAAACAUCUUUAUUUUGCCUCAUUUUAAAUAGUAUUUAGAUUGGGUGUAGACUUCUAUAUUGCCAAUUAGUUUCUUUUAGCACUGUAAAUACAGAUGUCCAGUAUUUUCAGAUUCAGUUAUUUCAGCUGAAAAGCUAGCUGAAAGUCUUGUUGCUCCUCUGAAGGUAAUAUGACUUUUUUCAAAAAAUACAUUUAUAAAAUUUUUUUUCUUUGCCUUGAUAGUUUUACUACAAGGUGCCUGGAUGAGACUUUCUCUGAAUUUGUCUUGCUUGGGGUUCAUAGAAUCUGUGACUUGAUGUCUUUCAUGAGUUUUGAAAAAUGCUAGCCAUUAUCUCUUAAAUAUUGCUAUUACUCUACUCCCUCUUCUCUUUCAGAUAUUUCAGUUACACCAAUGGCCAAUGUUUGCUCGUGUCUCAUAUGUCUCUUGUUCUAGUUUCUGGAUUUGUAUUCUUUUUUCCUUUUCACAUUCAGUCUGGAUAUUUUCUGCUGACCUAUAUUCCAGUUCACUAAUAAUGCUUUUCACUGUAUCUAAUUUGCUUAUAAAUAGAAAACCAUUGAUUGAGUUAUUAAUUUCAGUUAUAGAAUAGCCAGUGUAGACUCCAAUGCUUGGCUCCACUUCUCCACUUUUUCACCUAUUUUUUUCACCAUCUUCCAUUUUCUUCAACACACCAGUCAGAGUCGUUUUUAAAGACAUUUUAAACACCUCAGUGGCCUGUAGAUCUUAUCUUCUGUUUUUUGUUUCUUUUUAAUCUUAGUUUUUUGGCACACUUGGAGGGUUUUGAUUGAAUGCUAGACAUAGUAUUCAGGAAGGCAGAGAGGAUUUUUUUUUAAGUCAGAUUUUUUGAGGUAUAAUUUAAUACAGUAAAAUUCACCUAUUUUAGUUCAGUUCUAAGAGUUUCCUCUGUGACUUUUCCUUUGGCCCAUGGUUUAUUUAAAAUUGUGUUCUUUUACUUCCAAAUUAUUUGGGAUUUUUCUAGAUAUCUUUCUGUUCUUGAUUUCUGGCUUACCUCUAUCAGGGUCAGAGAACAAACUUAAUAUGAUUUCAAUUAUUUUAAAUUUGCCAAUGUUUAUUUUAUGGCCCAGAAUAUGGUCUAUGUUGGUGAAAGUUCAAUUUGAACUUGAAAAGAAUAUGUUUUAUGCUGUUGUCUACUGAAAAGUCUAUAUAUAAAAAAUAGAUUAAUAAACUGAUUAAUAGCCUGGUUCACCA-3'- Poly-A tail
  • Coding region
;
DNA
DNA (Gene ID: 2219)
ficolin 1
strand -
FCNM
NCBI CDS gene sequence (981 bp)
5'-ATGGAGCTGAGTGGAGCCACCATGGCCCGGGGGCTCGCTGTCCTGCTAGTCTTGTTCCTGCATATCAAGAACCTGCCTGCCCAGGCTGCGGACACATGTCCAGAGGTGAAGGTGGTGGGCCTGGAGGGCTCTGACAAGCTCACCATTCTCCGAGGCTGCCCGGGGCTGCCCGGGGCCCCAGGGCCAAAGGGAGAGGCAGGTGTCATTGGAGAGAGAGGAGAACGCGGTCTCCCTGGAGCCCCTGGAAAGGCAGGACCAGTGGGGCCCAAAGGAGACCGAGGAGAGAAGGGGATGCGTGGAGAGAAAGGAGACGCTGGGCAGTCTCAGTCGTGTGCGACAGGCCCACGCAACTGCAAGGACCTGCTAGACCGGGGGTATTTCCTGAGCGGCTGGCACACCATCTACCTGCCCGACTGCCGGCCCCTGACTGTGCTCTGTGACATGGACACGGACGGAGGGGGCTGGACCGTTTTCCAGCGGAGGATGGATGGCTCTGTGGACTTCTATCGGGACTGGGCCGCATACAAGCAGGGCTTCGGCAGTCAGCTGGGGGAGTTCTGGCTGGGGAATGACAACATCCACGCCCTGACTGCCCAGGGAAGCAGCGAGCTCCGTGTAGACCTGGTGGACTTTGAGGGCAACCACCAGTTTGCTAAGTACAAATCATTCAAGGTGGCTGACGAGGCAGAGAAGTACAAGCTGGTACTGGGAGCCTTTGTCGGGGGCAGTGCGGGTAATTCTCTAACGGGCCACAACAACAACTTCTTCTCCACCAAAGACCAAGACAATGATGTGAGTTCTTCGAATTGTGCTGAGAAGTTCCAAGGAGCCTGGTGGTACGCCGACTGTCATGCTTCAAACCTCAATGGTCTCTACCTCATGGGACCCCATGAGAGCTATGCCAATGGTATCAACTGGAGTGCGGCGAAGGGGTACAAATATAGCTACAAGGTGTCAGAGATGAAGGTGCGGCCCGCCTAG-3'
NCBI CDS gene sequence with introns (location: 134909798.. 134917871) (8074 bp)Download
NCBI CDS gene sequence with introns, 5'UTR and 3'UTR (location: 134903232.. 134917912) (14681 bp)Download
NCBI gene sequence (location: [134903232.. 134917912 + 1000]) (15681 bp)Download
How to cite: Schnider B., M'Rad Y., el Ahmadie J., de Brevern AG., Imberty A., Lisacek F., HumanLectome, an update of UniLectin for the annotation and prediction of human lectins, Nucleic Acids Reasearch doi.org/10.1093/nar/gkad905